The Sensitivity, Specificity, and Predictive Values of Serum Angiotensin-Converting Enzyme and Lysozyme in the Diagnosis of Sarcoid Optic Neuropathy
Listen to this summary
This study investigates the diagnostic performance of serum angiotensin-converting enzyme (s-ACE) and serum lysozyme in identifying sarcoid optic neuropathy (SON). The authors found that while both tests exhibited high specificity (97% for s-ACE and 98% for lysozyme), their sensitivity was low (21.4% for s-ACE and 33.3% for lysozyme), indicating that these biomarkers are not effective as general screening tools for SON.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
View all →May 29, 2026 · Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Six-Month Visual Outcomes in Pediatric Optic Neuritis: A Multicenter Study From South Korea
May 20, 2026 · Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Risk Factors and Social Determinants of Health for Retinal Artery Occlusion in the National Institutes of Health All of Us Program
More in Ophthalmology
View all →Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 22, 2026 · American journal of ophthalmology
Incidence of De Novo Glaucoma and Ocular Hypertension After DMEK vs DSAEK: A Systematic Review and Meta-Analysis
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


